Cristália purchase Ophthalmology company

Sao Paulo-the Cristália Laboratory has announced this week the acquisition of Latinofarma, maker of Ophthalmology segment. The purchase is part of pharmaceutical strategy to expand market share ophthalmic. "Doctors already know the Cristália, for we are leaders in Anesthesia for ophthalmic surgeries. With the acquisition, we have now with a complete portfolio of products to serve them, "said the President of Cristália, Ogari Pacheco, during the announcement of the acquisition of Latinofarma. The manufacturer of ophthalmic products has annual revenues of approximately $ 90 million, with the artificial tears account for 54% of revenues. Corticosteroids, anti-infective and ophthalmologic antiseptics are also some of the main products marketed by the company. The Latinofarma manufactures still aimed at ultimate consumer items in the category of non-prescription drugs and, for hospitals and clinics, provides anesthesia and eyedrops intended for inflammation and post-surgery treatments.